What amount sold does Celcuity Inc. report in Form D filings?

The latest linked filings report $303M sold across 9 identified offering(s). 8 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Celcuity Inc.'s most recent SEC filing?

Celcuity Inc.'s most recent Form D filing was on 2025-09-23.

How many investors does Celcuity Inc. have?

The most recent Form D filing lists 2 investor(s).

What type of securities does Celcuity Inc. offer?

Celcuity Inc.'s SEC Form D filings indicate debt offerings.

Celcuity Inc.

CIK: 0001603454·Biotechnology·MINNEAPOLIS, MN·Corporation

Reported Sold

$303,023,309

Total Filings

Identified Offerings

Last Filed

Sep 23, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 8 unlinked amendments excluded.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 23, 2025Form D/A — Amendment

Reported sold: $130,000,000 · Target: $352,700,000

Rule 506(b)·2 investors

Changed: Reported amount sold, Offering target, Reported investors, Reported revenue range, Sales commissions

Oct 15, 2024Form D/A — Amendment

Reported sold: $50,000,000 · Target: $50,000,000

Rule 506(b)·2 investors

Jun 28, 2024Form D/A — Amendment

Reported sold: $100,000,000 · Target: $184,500,000

Rule 506(b)·2 investors

Changed: Reported amount sold, Offering target, Reported investors, Sales commissions

Apr 25, 2024Form D/A — Amendment

Reported sold: $35,000,000 · Target: $75,375,000

Rule 506(b)·1 investor

Changed: Reported revenue range

Nov 27, 2023Form D/A — Amendment

Reported sold: $5,930,006 · Target: $6,612,667

Rule 506(b)·39 investors

Nov 27, 2023Form D/A — Amendment

Reported sold: $2,597,057 · Target: $2,975,746

Rule 506(b)·38 investors

Oct 26, 2023Form D — New notice

Reported sold: $50,000,000 · Target: $50,000,000

Rule 506(b)·2 investors

May 2, 2023Form D/A — Amendment

Reported sold: $35,000,000 · Target: $75,375,000

Rule 506(b)·1 investor

Changed: Reported amount sold, Offering target, Sales commissions

Nov 28, 2022Form D/A — Amendment

Reported sold: $2,597,057 · Target: $2,975,746

Rule 506(b)·38 investors

Nov 28, 2022Form D/A — Amendment

Reported sold: $5,930,006 · Target: $6,612,667

Rule 506(b)·39 investors

May 26, 2022Form D — New notice

Reported sold: $99,999,998 · Target: $155,999,997

Rule 506(b)·11 investors

Apr 8, 2022Form D/A — Amendment

Reported sold: $15,000,000 · Target: $25,625,000

Rule 506(b)·1 investor

Nov 22, 2021Form D/A — Amendment

Reported sold: $5,930,006 · Target: $6,612,667

Rule 506(b)·39 investors

Nov 22, 2021Form D/A — Amendment

Reported sold: $2,597,057 · Target: $2,975,746

Rule 506(b)·38 investors

Apr 14, 2021Form D — New notice

Reported sold: $5,000,000 · Target: $5,000,000

Rule 506(b)·1 investor

Apr 14, 2021Form D — New notice

Reported sold: $15,000,000 · Target: $25,625,000

Rule 506(b)·1 investor

Nov 2, 2020Form D/A — Amendment

Reported sold: $5,930,006 · Target: $6,612,667

No verified predecessor available.

Rule 506(b)·39 investors

Nov 2, 2020Form D/A — Amendment

Reported sold: $2,597,057 · Target: $2,975,746

No verified predecessor available.

Rule 506(b)·38 investors

Nov 7, 2018Form D/A — Amendment

Reported sold: $2,593,305 · Target: $2,975,746

Rule 506(b)·38 investors

Changed: Reported amount sold

Nov 7, 2018Form D/A — Amendment

Reported sold: $5,930,006 · Target: $6,612,667

Rule 506(b)·39 investors

Changed: Reported amount sold

Nov 7, 2017Form D/A — Amendment

Reported sold: $2,587,500 · Target: $2,975,746

Rule 506(b)·38 investors

Changed: Offering target

Nov 7, 2017Form D/A — Amendment

Reported sold: $5,750,000 · Target: $6,612,667

Rule 506(b)·39 investors

Changed: Offering target

May 19, 2017Form D — New notice

Reported sold: $2,587,500 · Target: $2,587,500

Rule 506(b)·38 investors

May 2, 2017Form D — New notice

Reported sold: $5,750,000 · Target: $5,750,000

Rule 506(b)·39 investors

Feb 26, 2016Form D/A — Amendment

Reported sold: $5,175,000 · Target: $5,175,000

Rule 506(b)·40 investors

Changed: Reported amount sold, Reported investors, Sales commissions

Feb 26, 2016Form D — New notice

Reported sold: $325,000 · Target: $3,000,000

Rule 506(b)·6 investors

Dec 18, 2015Form D — New notice

Reported sold: $2,150,000 · Target: $5,175,000

Rule 506(b)·12 investors

Mar 24, 2014Form D — New notice

Reported sold: $4,000,000 · Target: $4,862,069

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

$10,075,069

Amendment Rate

68%

Latest reported sold across 9 identified offerings

$303,023,309

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

8 unlinked amendments excluded.

Key People

Brian F. Sullivan

Related Person

Appears on 27 filings

Lance G. Laing

Related Person

Appears on 27 filings

David F. Dalvey

Related Person

Appears on 27 filings

Vicky Hahne

Related Person

Appears on 22 filings

Richard J. Nigon

Related Person

Appears on 22 filings

Richard E. Buller

Related Person

Appears on 18 filings

Leo T. Furcht

Related Person

Appears on 10 filings

Polly A. Murphy

Related Person

Appears on 10 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 23, 2025	Amendment	$352,700,000	$130,000,000	2
Oct 15, 2024	Amendment	$50,000,000	$50,000,000	2
Jun 28, 2024	Amendment	$184,500,000	$100,000,000	2
Apr 25, 2024	Amendment	$75,375,000	$35,000,000	1
Nov 27, 2023	Amendment	$6,612,667	$5,930,006	39
Nov 27, 2023	Amendment	$2,975,746	$2,597,057	38
Oct 26, 2023	New	$50,000,000	$50,000,000	2
May 2, 2023	Amendment	$75,375,000	$35,000,000	1
Nov 28, 2022	Amendment	$6,612,667	$5,930,006	39
Nov 28, 2022	Amendment	$2,975,746	$2,597,057	38
May 26, 2022	New	$155,999,997	$99,999,998	11
Apr 8, 2022	Amendment	$25,625,000	$15,000,000	1
Nov 22, 2021	Amendment	$6,612,667	$5,930,006	39
Nov 22, 2021	Amendment	$2,975,746	$2,597,057	38
Apr 14, 2021	New	$25,625,000	$15,000,000	1
Apr 14, 2021	New	$5,000,000	$5,000,000	1
Nov 2, 2020	Amendment	$6,612,667	$5,930,006	39
Nov 2, 2020	Amendment	$2,975,746	$2,597,057	38
Nov 7, 2018	Amendment	$2,975,746	$2,593,305	38
Nov 7, 2018	Amendment	$6,612,667	$5,930,006	39
Nov 7, 2017	Amendment	$2,975,746	$2,587,500	38
Nov 7, 2017	Amendment	$6,612,667	$5,750,000	39
May 19, 2017	New	$2,587,500	$2,587,500	38
May 2, 2017	New	$5,750,000	$5,750,000	39
Feb 26, 2016	Amendment	$5,175,000	$5,175,000	40
Feb 26, 2016	New	$3,000,000	$325,000	6
Dec 18, 2015	New	$5,175,000	$2,150,000	12
Mar 24, 2014	New	$4,862,069	$4,000,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Medical 21, Inc.

Biotechnology

Offering target: $20,000,000

Filed Oct 22, 2026